Table 1: Delays in Initiation of Antithrombotic Therapies in Patients with Newly Diagnosed AF.
| Time to Initiation | Acetylsalicylic acid/clopidogrel (n=21,781) | Warfarin (n=4,408) |
|---|---|---|
| General population | ||
| ≤30 days | 48.0% | 5.2% |
| 31 days to 1 year | 10.5% | 12.4% |
| >1 year to 3 years | 13.1% | 17.1% |
| >3 years | 28.4% | 65.3% |
| CHA2DS2-VASc 2–4 | ||
| ≤30 days | 50.7% | 4.8% |
| 31 days to 1 year | 10.2% | 12.5% |
| 1 year to 3 years | 13.6% | 17.9% |
| >3 years | 25.5% | 64.8% |
| CHA2DS2-VASc >5 | ||
| ≤30 days | 67.1% | 7.9% |
| 31 days to 1 year | 8.8% | 18.4% |
| 1 year to 3 years | 10.9% | 25.4% |
| >3 years | 13.2% | 48.3% |